Key Capital Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
Key Capital Management's NVO Position: Q3 2026 in Review
Key Capital Management increased its Novo Nordisk (NVO) stake by 1,633% in Q3 2026, buying an estimated $13.6K and bringing the position to 312 shares worth $11.8K. The position accounts for ﹤0.01% of the portfolio, ranked #360.
Key Capital Management first reported a position in NVO in Q4 2025 and has held it in 4 quarters since. 1,236 funds tracked by Wall St. Rank hold NVO as of Q3 2026.
- Key Capital Management held 312 shares of Novo Nordisk worth $11.8K as of Q3 2026.
- Key Capital Management bought 294 Novo Nordisk shares in Q3 2026, an estimated $13.6K.
- Novo Nordisk made up ﹤0.01% of Key Capital Management's portfolio in Q3 2026, its #360 holding.
- Key Capital Management first reported a position in Novo Nordisk in Q4 2025 and has held it in 4 quarters since.
- 1,236 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2026.
Based on Key Capital Management's 13F filing for Q3 2026, filed 3 Nov 2026.